Dongliang Yang to Recombinant Proteins
This is a "connection" page, showing publications Dongliang Yang has written about Recombinant Proteins.
Connection Strength
0.023
-
Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China. BMC Gastroenterol. 2019 May 02; 19(1):65.
Score: 0.023